A detailed history of First Citizens Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, First Citizens Financial Corp holds 4,524 shares of LLY stock, worth $4.1 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
4,524
Previous 5,339 15.27%
Holding current value
$4.1 Million
Previous $3.11 Million 13.08%
% of portfolio
2.1%
Previous 2.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 31, 2024

SELL
$592.2 - $792.28 $482,643 - $645,708
-815 Reduced 15.27%
4,524 $3.52 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $21,007 - $24,765
-40 Reduced 0.74%
5,339 $3.11 Million
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $103,458 - $142,633
-238 Reduced 4.24%
5,379 $2.89 Million
Q2 2023

Jul 07, 2023

SELL
$350.74 - $468.98 $1.23 Million - $1.65 Million
-3,510 Reduced 38.46%
5,617 $2.63 Million
Q4 2022

Jan 11, 2023

SELL
$321.55 - $374.67 $45,017 - $52,453
-140 Reduced 1.51%
9,127 $3.34 Million
Q3 2022

Oct 12, 2022

SELL
$296.48 - $337.87 $2.09 Million - $2.38 Million
-7,037 Reduced 43.16%
9,267 $3 Million
Q1 2022

Apr 18, 2022

BUY
$234.69 - $291.66 $3.24 Million - $4.03 Million
13,822 Added 556.89%
16,304 $4.67 Million
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $34,791 - $42,815
-157 Reduced 5.95%
2,482 $573,000
Q1 2021

Apr 09, 2021

SELL
$164.32 - $212.72 $28,756 - $37,226
-175 Reduced 6.22%
2,639 $493,000
Q3 2020

Oct 16, 2020

SELL
$146.22 - $169.13 $18,277 - $21,141
-125 Reduced 4.25%
2,814 $417,000
Q2 2020

Jul 30, 2020

SELL
$136.42 - $164.18 $22,236 - $26,761
-163 Reduced 5.25%
2,939 $483,000
Q1 2020

Apr 27, 2020

SELL
$119.05 - $147.35 $4,166 - $5,157
-35 Reduced 1.12%
3,102 $430,000
Q4 2019

Jan 21, 2020

BUY
$106.92 - $132.43 $335,408 - $415,432
3,137 New
3,137 $412,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Citizens Financial Corp Portfolio

Follow First Citizens Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Financial Corp with notifications on news.